相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma
Nadine Hoemberg et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
Georg Gasteiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumueller et al.
NATURE (2013)
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
G. Chitadze et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma: Implications for Therapeutic Cell Transfer
Margarethe Przewoznik et al.
JOURNAL OF IMMUNOTHERAPY (2012)
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Renaud Sabatier et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer Immunoediting of the NK Group 2D Ligand H60a
Timothy O'Sullivan et al.
JOURNAL OF IMMUNOLOGY (2011)
Requirements for control of B-cell lymphoma by NK cells
Christoph D. Brenner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion
Alexandra Ziegler et al.
BLOOD (2009)
DC therapy induces long-term NK reactivity to tumors via host DC
Kanako Shimizu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice
Biljana Zafirova et al.
IMMUNITY (2009)
Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells
Nicole Schwinn et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Direct and natural killer cell-mediated antitumor effects of low-dose Bortezomib in hepatocellular carcinoma
Sorin Armeanu et al.
CLINICAL CANCER RESEARCH (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
Gabricla Alexe et al.
CANCER RESEARCH (2007)
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: Evidence of a two-stage process in resting NK cell activation
Janet North et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of the NKG2D receptor for tumor immunity
Jerome D. Coudert et al.
SEMINARS IN CANCER BIOLOGY (2006)
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
Francois Bertucci et al.
CANCER RESEARCH (2006)
Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
R Gazit et al.
NATURE IMMUNOLOGY (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
DE Oppenheim et al.
NATURE IMMUNOLOGY (2005)
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
K Wiemann et al.
JOURNAL OF IMMUNOLOGY (2005)
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction
C Adam et al.
BLOOD (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Natural killer: can they be useful as adoptive immunotherapy for cancer?
S Arai et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses
R Mocikat et al.
IMMUNITY (2003)
Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for marine NKG2D
LN Carayannopoulos et al.
JOURNAL OF IMMUNOLOGY (2002)
The role of the NKG2D immunoreceptor in immune cell activation and natural killing
AM Jamieson et al.
IMMUNITY (2002)
A ligand for the murine NK activation receptor Ly-49D:: Activation of tolerized NK cells from β2-microglobulin-deficient mice
H Furukawa et al.
JOURNAL OF IMMUNOLOGY (2002)
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors
H Arase et al.
SCIENCE (2002)
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer
FR Villegas et al.
LUNG CANCER (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
NK cells and NKT cells in innate defense against viral infections
CA Biron et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60
CA O'Callaghan et al.
IMMUNITY (2001)
Burkitt lymphoma in the mouse
AL Kovalchuk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
A Diefenbach et al.
NATURE IMMUNOLOGY (2000)
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
A Cerwenka et al.
IMMUNITY (2000)
Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype:: An adaptive component of NK cell-mediated responses
R Glas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
